Published in Neuropsychiatr Dis Treat on January 31, 2017
Inositol phosphates and cell signalling. Nature (1989) 17.78
Magnesium gates glutamate-activated channels in mouse central neurones. Nature (1984) 13.67
A molecular mechanism for the effect of lithium on development. Proc Natl Acad Sci U S A (1996) 11.37
Lithium amplifies agonist-dependent phosphatidylinositol responses in brain and salivary glands. Biochem J (1982) 8.16
Histone deacetylase is a direct target of valproic acid, a potent anticonvulsant, mood stabilizer, and teratogen. J Biol Chem (2001) 6.85
The effects of lithium ion and other agents on the activity of myo-inositol-1-phosphatase from bovine brain. J Biol Chem (1980) 6.02
Lithium induces autophagy by inhibiting inositol monophosphatase. J Cell Biol (2005) 5.21
Declining NAD(+) induces a pseudohypoxic state disrupting nuclear-mitochondrial communication during aging. Cell (2013) 4.85
A key role for TRPM7 channels in anoxic neuronal death. Cell (2003) 4.46
Magnesium: physiology and pharmacology. Br J Anaesth (1999) 4.33
Neural and developmental actions of lithium: a unifying hypothesis. Cell (1989) 4.13
Poly(ADP-ribose) polymerase is a mediator of necrotic cell death by ATP depletion. Proc Natl Acad Sci U S A (1999) 3.85
The TRPM7 channel is inactivated by PIP(2) hydrolysis. Nat Cell Biol (2002) 3.63
Pathophysiology of traumatic brain injury. Br J Anaesth (2007) 3.06
A beta-arrestin 2 signaling complex mediates lithium action on behavior. Cell (2008) 2.76
The eEF2 kinase confers resistance to nutrient deprivation by blocking translation elongation. Cell (2013) 2.74
Magnesium sulfate for neuroprotection after traumatic brain injury: a randomised controlled trial. Lancet Neurol (2007) 2.68
Metabolic crisis without brain ischemia is common after traumatic brain injury: a combined microdialysis and positron emission tomography study. J Cereb Blood Flow Metab (2005) 2.52
Mitochondrial dysfunction in bipolar disorder. Bipolar Disord (2000) 2.32
Regulation of cellular magnesium. Front Biosci (2000) 2.19
Basic pharmacology of valproate: a review after 35 years of clinical use for the treatment of epilepsy. CNS Drugs (2002) 2.13
Lithium inhibits glycogen synthase kinase-3 by competition for magnesium. Biochem Biophys Res Commun (2001) 2.08
The nicotinamide phosphoribosyltransferase: a molecular link between metabolism, inflammation, and cancer. Cancer Res (2009) 2.04
Regulation of free and bound magnesium in rat hepatocytes and isolated mitochondria. J Biol Chem (1986) 2.04
Evidence that lithium alters phosphoinositide metabolism: chronic administration elevates primarily D-myo-inositol-1-phosphate in cerebral cortex of the rat. J Neurochem (1981) 1.94
Persistently low extracellular glucose correlates with poor outcome 6 months after human traumatic brain injury despite a lack of increased lactate: a microdialysis study. J Cereb Blood Flow Metab (2003) 1.93
The purification and properties of myo-inositol monophosphatase from bovine brain. Biochem J (1988) 1.80
Receptors for the age of anxiety: pharmacology of the benzodiazepines. Science (1980) 1.76
Enzymes in the NAD+ salvage pathway regulate SIRT1 activity at target gene promoters. J Biol Chem (2009) 1.70
Magnesium transport across cell membranes. J Membr Biol (1984) 1.68
NAD+ and vitamin B3: from metabolism to therapies. J Pharmacol Exp Ther (2007) 1.67
The role of lithium in the treatment of bipolar disorder: convergent evidence for neurotrophic effects as a unifying hypothesis. Bipolar Disord (2009) 1.62
Intracellular magnesium and magnesium buffering. Biometals (2002) 1.62
Association of psychiatric disorders and sleep apnea in a large cohort. Sleep (2005) 1.62
Magnesium as a regulatory cation: criteria and evaluation. Magnesium (1987) 1.56
The dynamic regulation of NAD metabolism in mitochondria. Trends Endocrinol Metab (2012) 1.55
Lithium and bipolar mood disorder: the inositol-depletion hypothesis revisited. Mol Psychiatry (2005) 1.49
Definition of a metal-dependent/Li(+)-inhibited phosphomonoesterase protein family based upon a conserved three-dimensional core structure. Proc Natl Acad Sci U S A (1995) 1.47
Cellular magnesium homeostasis. Arch Biochem Biophys (2011) 1.46
The new '5-HT' hypothesis of depression: cell-mediated immune activation induces indoleamine 2,3-dioxygenase, which leads to lower plasma tryptophan and an increased synthesis of detrimental tryptophan catabolites (TRYCATs), both of which contribute to the onset of depression. Prog Neuropsychopharmacol Biol Psychiatry (2010) 1.44
Fructose-1,6-bisphosphate has anticonvulsant activity in models of acute seizures in adult rats. J Neurosci (2007) 1.43
SIRT1-dependent regulation of chromatin and transcription: linking NAD(+) metabolism and signaling to the control of cellular functions. Biochim Biophys Acta (2009) 1.41
Serum phosphate and anxiety in major depression. Psychiatry Res (1987) 1.40
Molecular actions and therapeutic potential of lithium in preclinical and clinical studies of CNS disorders. Pharmacol Ther (2010) 1.39
Inositol polyphosphate 1-phosphatase from calf brain. Purification and inhibition by Li+, Ca2+, and Mn2+. J Biol Chem (1987) 1.38
Zinc-induced neurotoxicity mediated by transient receptor potential melastatin 7 channels. J Biol Chem (2010) 1.38
Valproate administered after traumatic brain injury provides neuroprotection and improves cognitive function in rats. PLoS One (2010) 1.36
Gammahydroxybutyrate: an endogenous regulator of energy metabolism. Neurosci Biobehav Rev (1989) 1.32
Inositol pyrophosphates: between signalling and metabolism. Biochem J (2013) 1.31
Concentration, compartmentation and metabolic function of intracellular free Mg2+. Magnes Res (2006) 1.29
Activation of TRPM7 channels by phospholipase C-coupled receptor agonists. J Biol Chem (2006) 1.21
Direct quantitation of Mg2+-RNA interactions by use of a fluorescent dye. Methods Enzymol (2009) 1.20
Synthesis of phosphoribosylpyrophosphate in mammalian cells. Adv Enzymol Relat Areas Mol Biol (1979) 1.18
The biochemistry of magnesium. Ann N Y Acad Sci (1969) 1.16
Elevated cerebrospinal fluid lactate concentrations in patients with bipolar disorder and schizophrenia: implications for the mitochondrial dysfunction hypothesis. Biol Psychiatry (2008) 1.14
Plasma brain derived neurotrophic factor (BDNF) and response to ketamine in treatment-resistant depression. Int J Neuropsychopharmacol (2013) 1.10
Nicotinamide offers multiple protective mechanisms in stroke as a precursor for NAD+, as a PARP inhibitor and by partial restoration of mitochondrial function. Pharmacology (2003) 1.08
Oxidative stress in neurodegeneration and available means of protection. Front Biosci (2008) 1.08
Fructose-1,6-bisphosphate preserves intracellular glutathione and protects cortical neurons against oxidative stress. Brain Res (2003) 1.06
Structural similarities between fructose-1,6-bisphosphatase and inositol monophosphatase. Biochem Biophys Res Commun (1993) 1.05
Mysteries of magnesium homeostasis. Circ Res (2000) 1.04
Adenosine, ketogenic diet and epilepsy: the emerging therapeutic relationship between metabolism and brain activity. Curr Neuropharmacol (2009) 1.04
Increased uric acid levels in drug-naïve subjects with bipolar disorder during a first manic episode. Prog Neuropsychopharmacol Biol Psychiatry (2010) 1.03
Phosphoglucomutase is an in vivo lithium target in yeast. J Biol Chem (2001) 1.03
Rapid recovery from major depression using magnesium treatment. Med Hypotheses (2006) 1.02
Intracellular pathways underlying the effects of lithium. Behav Pharmacol (2010) 1.02
Quinolinic-phosphoribosyl transferase activity is decreased in epileptic human brain tissue. Epilepsia (1988) 1.01
Lithium ameliorates neurodegeneration, suppresses neuroinflammation, and improves behavioral performance in a mouse model of traumatic brain injury. J Neurotrauma (2011) 0.99
Excess cardiovascular and suicide mortality of affective disorders may be reduced by lithium prophylaxis. J Affect Disord (1995) 0.99
Seizure control by ketogenic diet-associated medium chain fatty acids. Neuropharmacology (2012) 0.99
The biological relevance of the binding of calcium ions by inositol phosphates. J Biol Chem (1993) 0.99
Lithium increases PGC-1alpha expression and mitochondrial biogenesis in primary bovine aortic endothelial cells. FEBS J (2007) 0.98
Rapid, reliable in vivo assays of human phosphate metabolites by nuclear magnetic resonance. Clin Chem (1989) 0.97
Galactose-1-phosphate in the pathophysiology of galactosemia. Eur J Pediatr (1995) 0.97
Letter: Lithium and magnesium-dependent enzymes. Lancet (1974) 0.96
The distribution of lithium and its effects on the distribution and excretion of other ions in the rat. Br J Pharmacol (1973) 0.96
Involvement of the glycogen synthase kinase-3 signaling pathway in TBI pathology and neurocognitive outcome. PLoS One (2011) 0.95
The role of Ca2+ in cell killing. Chem Res Toxicol (1991) 0.95
Double-blind, controlled trial of inositol treatment of depression. Am J Psychiatry (1995) 0.95
KCNE1-KCNQ1 osmoregulation by interaction of phosphatidylinositol-4,5-bisphosphate with Mg2+ and polyamines. J Physiol (2010) 0.95
TRPM7 and ischemic CNS injury. Neuroscientist (2005) 0.95
Lithium and neuroprotection: translational evidence and implications for the treatment of neuropsychiatric disorders. Neuropsychiatr Dis Treat (2013) 0.95
Effect of lithium maintenance on suicidal behavior in major mood disorders. Ann N Y Acad Sci (1997) 0.95
Chronic creatine supplementation alters depression-like behavior in rodents in a sex-dependent manner. Neuropsychopharmacology (2010) 0.95
Polyamines in neurotrauma. Ubiquitous molecules in search of a function. Biochem Pharmacol (1992) 0.95
ATP depletion + pyrimidine depletion can markedly enhance cancer therapy: fresh insight for a new approach. Cancer Res (2000) 0.93
Competition between Li+ and Mg2+ in metalloproteins. Implications for lithium therapy. J Am Chem Soc (2011) 0.93
Overview of the mechanism of action of lithium in the brain: fifty-year update. J Clin Psychiatry (2000) 0.91
Energy metabolism in hypoxic astrocytes: protective mechanism of fructose-1,6-bisphosphate. Neurochem Res (1995) 0.91
Anticonvulsants attenuate amyloid beta-peptide neurotoxicity, Ca2+ deregulation, and cytoskeletal pathology. Neurobiol Aging (1995) 0.91
Acute increases in plasma mammalian target of rapamycin, glycogen synthase kinase-3β, and eukaryotic elongation factor 2 phosphorylation after ketamine treatment in three depressed patients. Biol Psychiatry (2012) 0.91
Reduced frontal cortex inositol levels in postmortem brain of suicide victims and patients with bipolar disorder. Am J Psychiatry (1997) 0.91
Decline in intracellular free Mg2+ is associated with irreversible tissue injury after brain trauma. J Biol Chem (1988) 0.90
The common inositol-reversible effect of mood stabilizers on neurons does not involve GSK3 inhibition, myo-inositol-1-phosphate synthase or the sodium-dependent myo-inositol transporters. Mol Cell Neurosci (2006) 0.89
Galactose-1-phosphate is a regulator of inositol monophosphatase: a fact or a fiction? Med Hypotheses (2003) 0.89
Crosstalk between poly(ADP-ribose) polymerase and sirtuin enzymes. Mol Aspects Med (2013) 0.89
Magnesium ions inhibit the stimulation of inositol phospholipid hydrolysis by endogenous excitatory amino acids in primary cultures of cerebellar granule cells. J Neurochem (1987) 0.88
Is bipolar disorder a mitochondrial disease? J Psychiatry Neurosci (2007) 0.88
Adenosine triphosphate turnover in humans. Decreased degradation during relative hyperphosphatemia. J Clin Invest (1989) 0.86
Evidence that the etiology of the syndrome containing type 2 diabetes mellitus results from abnormal magnesium metabolism. Can J Physiol Pharmacol (2008) 0.86